|
| Press Releases |
|
|
| Monday, September 1, 2025 |
|
|
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025 |
| ABVC BioPharma, Inc. (NASDAQ: ABVC) (ABVC or the Company), a clinical-stage biopharmaceutical company developing innovative therapies in oncology, ophthalmology, and central nervous system (CNS) disorders, today announced that its partner OncoX BioPharma has delivered $450,000 in licensing payments in the third quarter of 2025, including $350,000 received in August. more info >> |
|
| Friday, August 29, 2025 |
|
|
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025 |
| ABVC BioPharma, Inc. (NASDAQ: ABVC) (ABVC or the Company), a clinical-stage biopharmaceutical company developing innovative therapies in oncology, ophthalmology, and central nervous system (CNS) disorders, today announced that its partner OncoX BioPharma has delivered $450,000 in licensing payments in the third quarter of 2025 , including $350,000 received in August. These more info >> |
|
|
|
|
|
|
